newsfilter
← Latest News
Business Wire·

Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29

  • Glaukos Corporation (NYSE: GKOS) plans to release third quarter 2025 financial results after the market close on Wednesday, October 29, 2025.
  • Management will discuss the results during a conference call & simultaneous webcast at 1:30 p.m. PT (4:30 p.m. ET) on October 29, 2025.
  • The live webcast link is available at http://investors.glaukos.com, with a replay archived following the call.
  • Conference call dial-in numbers are 800-715-9871 (U.S.) or 646-307-1963 (International) with Conference ID 5255602.
  • Glaukos develops novel therapies for glaucoma, corneal disorders, & retinal diseases, having launched its first MIGS device in 2012.
  • In 2024, Glaukos commenced commercial launch activities for iDose ® TR, a long-duration intracameral procedural pharmaceutical.
  • The company markets the only FDA-approved corneal cross-linking therapy for keratoconus using a proprietary bio-activated pharmaceutical.